×
0.267605633802817 0.267605633802817 0.309859154929578 0.126760563380282 0.267605633802817 -0.0140845070422533 0.225352112676057 0.225352112676057
Stock impact report

New Clinical Data Support Bertilimumab Activity in Bullous Pemphigoid

Immune Pharmaceuticals Inc Ne (IMNP)  More Company Research Source: GlobeNewswire
US:NASDAQ Investor Relations: immunepharma.com/investor-relations
PDF No anti-drug antibodies observed and multidose pharmacokinetics as expected FORT LEE, N.J., Oct. 29, 2018 (GLOBE NEWSWIRE) -- Immune Pharmaceuticals, Inc. (OTCQB: IMNP) (“Immune” or the “Company”), a biopharmaceutical company developing novel therapeutic agents for the treatment of immunologic and inflammatory diseases, today released additional results from its positive, proof-of-concept phase 2a trial of bertilimumab in bullous pemphigoid.  These results include pharmacokinetic (PK), pharmacodynamic (PD) and anti-drug antibody data. The key observations are: No anti-drug antibodies were observed in any subject at any timepoint. The PK profile of bertilimumab in elderly bullous pemphigoid patients is similar to the profile observed in young, healthy volunteers and supports a once every other week dosing regimen.  The mean serum concentration of autoantibodies to BP180 (type 17 collagen), which are important in the pathogenesis of BP, declined over the course of the study.  In th [Read more]
Impact snapshot Event time: IMNP
Last Price
Price Change
Price Change %
Volume Shares
Max Up
Max Down
Volume Ratio
%
Performance comparison Updated
Event Day
Stock performance from the time of news release until the following 4pm ET market close
Last price at news event
Since Event
Multi-day stock performance from the time of the news release
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
LAST
PRICE AT
NEWS EVENT
SINCE EVENT
Multi-day stock performance from the time of the news release
Last price
VWAP
High:
Max up
High:
Low:
Max down
Low:
%
Post news range
%
Price change

Price Change Percentage


S&P 500
(SPX)

%

Volume ratio
%

Volume
Ticks

Avg transaction size

Opt-in for
IMNP alerts
from News Quantified
Opt-in for
IMNP alerts

from News Quantified
Opt-in for
IMNP alerts

from News Quantified